Do-Youn Oh

基本信息

Career Trajectory

Bio

Specialty
1 Gastic cancer , Pancreatic cancer , Biliary tract cancer , Neuroendocrine tumor , Clinical trial , Clinical trial for drug development
2 Gastic cancer , Pancreatic cancer , Biliary tract cancer , Neuroendocrine tumor , Clinical trial , Clinical trial for drug development

Research Interests

Papers共 1028 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

KEYMAKER-U06: Phase 1/2 Umbrella Platform Study of TROP2 Antibody-Drug Conjugate Sacituzumab Tirumotecan Plus Pembrolizumab Plus Chemotherapy (substudy 06C) and Sacituzumab Tirumotecan Plus Paclitaxel (substudy 06D) in Gastroesophageal Adenocarcinoma

Do-Youn Oh,Jianming Xu,Josep Tabernero,Eric Van Cutsem, Tian He, Sucharita Bhaumik,Pooja Bhagia,Yelena Y. Janjigian

Journal of Clinical Oncologyno. 4_suppl (2025)

Cited0Views0Bibtex

Pembrolizumab or Placebo Plus Chemotherapy for Advanced HER2-negative Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma: an Updated Analysis of KEYNOTE-859 for Patients Enrolled in Asia

Chia Jui Yen,Do-Youn Oh,Yuxian Bai,Min-Hee Ryu,Jeeyun Lee,Jin Li,Lin Yang,Hisateru Yasui,Hiroshi Yabusaki,Ka On Lam,Kensei Yamaguchi,Kun-Huei Yeh, Lina Yin,Pierre Leconte,Pooja Bhagia,Sun Young Rha

Journal of Clinical Oncologyno. 4_suppl (2025): 464-464

Cited0Views0Bibtex

Summary of Research: Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02

Ana Oaknin,Jung-Yun Lee,Vicky Makker,Do-Youn Oh,Susana Banerjee,Antonio González-Martín,Kyung Hae Jung,Iwona Ługowska,Luis Manso,Aránzazu Manzano,Bohuslav Melichar,Salvatore Siena,Daniil Stroyakovskiy,Anitra Fielding,Soham Puvvada, Ann Smith,Funda Meric-Bernstam

Advances in Therapyno. 5 (2025): 2015-2018

Cited0Views0WOSBibtex

A Phase III Randomized Study of First-Line NUC-1031/cisplatin Vs. Gemcitabine/cisplatin in Advanced Biliary Tract Cancer

Jennifer J Knox,Mairéad G McNamara, Igor S Bazin,Do-Youn Oh, Oleksii Zubkov,Valeriy Breder,Li-Yuan Bai,Alan Christie,Lipika Goyal, David P Cosgrove,Christoph Springfeld,Katrin M Sjoquist,Joon Oh Park,Helena Verdaguer,Chiara Braconi,Paul J Ross,Aimery De Gramont,Rachna T Shroff, John R Zalcberg,Daniel H Palmer, Jonathan R Smith,Elisabeth Oelmann, Theresa Bruce,Juan W Valle

Journal of hepatology (2025)

Cited0Views0WOSBibtex

Phase 1/2 Study of the HER3-directed Antibody-Drug Conjugate Patritumab Deruxtecan (MK-1022) As Monotherapy in Patients with Gastrointestinal Cancers

Do-Youn Oh,Tae Won Kim, Ariel Aguilo, Naimin Jing, Rishi Jain,David E. Adelberg,Michael J. Pishvaian

Journal of Clinical Oncologyno. 4_suppl (2025)

Cited0Views0Bibtex

Updated Results from the Trastuzumab Deruxtecan (T-Dxd) 5.4 Mg/kg Triplet Combination of DESTINY-Gastric03 (DG-03): First-line (1L) T-DXd with Fluoropyrimidine (FP) and Pembrolizumab in Advanced/metastatic HER2-positive (HER2+) Esophageal Adenocarcinoma, Gastric Cancer (GC), or Gastroesophageal Junction Adenocarcinoma (GEJA)

Yelena Y. Janjigian,Hanneke W.M. Van Laarhoven,Sun Young Rha,Vadim Kozlov,Do-Youn Oh,Adriano Gravina,Liane Rapatoni,Hirokazu Shoji,Ralf Dieter Hofheinz,Li-Tzong Chen,Hugo Ford,Maxime Chenard-Poirier,Victoria de Giorgio-Miller, Yi-Ting Chang, Obinna Anadu,Jeeyun Lee

Journal of Clinical Oncologyno. 4_suppl (2025): 448-448

Cited0Views0Bibtex

Phase 1/2 Study of the Trophoblast Cell Surface Antigen 2 (TROP2) Antibody-Drug Conjugate (ADC) Sacituzumab Tirumotecan (Sac-Tmt) As Monotherapy or Combination Therapy in Gastrointestinal Cancers: LIGHTBEAM-02A

Michael J. Pishvaian,Takayuki Yoshino,Colin D. Weekes,Makoto Ueno,Richard S. Finn, Naimin Jing,Ken Hatogai,David E. Adelberg,Do-Youn Oh

Journal of Clinical Oncologyno. 4_suppl (2025)

Cited0Views0Bibtex

Pembrolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients with Advanced HER2-negative Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma Enrolled in the Republic of Korea: KEYNOTE-859

Sun Young Rha,Jeeyun Lee,Min-Hee Ryu, Lina Yin,Pierre Leconte,Pooja Bhagia,Do-Youn Oh

Journal of Clinical Oncologyno. 4_suppl (2025): 428-428

Cited0Views0Bibtex

A Phase 2 Study to Assess the Safety and Efficacy of FLX475 (tivumecirnon) Combined with Pembrolizumab in Patients with Advanced or Metastatic Gastric Cancer

Do-Youn Oh,Min-Hee Ryu,Jun-Eul Hwang, Jaeyong Cho,Dae Young Zang,Sang Cheul Oh,Jeeyun Lee, Keun-Wook Lee,Sun Young Rha,Byoung Yong Shim, William Ho,Michael Jon Chisamore, Paul Dong Rhee,Sooa Jung, Taewan Kim,Jiyeon Yoon, Hosung Jang,Eunhye Baek,Young Su Noh

Journal of Clinical Oncologyno. 4_suppl (2025): 426-426

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Professor

Papers共 1028 篇Author StatisticsCo-AuthorSimilar Experts